Holen Sie sich die Stockscreener-App
0.7298
0.38%
-0.0028
Finanzdaten der Cognition Therapeutics Inc-Aktie (CGTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
12.24%
7.738
|
8.817 | 13.67 | 6.375 | 13.98 |
| Operating Income/Loss |
12.24%
-7.738
|
-8.817 | -13.67 | -6.375 | -13.98 |
| Net Income/Loss |
13.96%
-3.932
|
-4.57 | -3.343 | -4.93 | -6.734 |
| Basic Average Shares |
1.61%
90.62
|
89.19 | - | 77.95 | 63.69 |
| Diluted Average Shares |
1.61%
90.62
|
89.19 | - | 77.95 | 63.69 |
| Basic Earnings Per Share |
20.00%
-0.04
|
-0.05 | - | -0.06 | -0.11 |
| Diluted Earnings Per Share |
20.00%
-0.04
|
-0.05 | - | -0.06 | -0.11 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):